EarningsQ2 2024 Earnings Report

Sarepta Therapeutics (AB3A) Q2 2024 Earnings Report

6 Followers

DE:AB3A Q2 2024 EPS Results

Actual EPS€0.06

Consensus EPS-€0.12

Beat/MissBeat by +€0.18

One Year Ago EPS-€0.24

Actual Revenue€323.67M

Expected Revenue€351.72M

Beat/MissMissed by -€28.05M

YoY Revenue Growth+38.93%

QuarterQ2 2024

Date08/07/2024

TimeAfter Close

Conference CallWednesday, August 7, 2024

DE:AB3A Upcoming Earnings

Sarepta Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

DE:AB3A Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	0.10 / -	-1.605	―
Aug 05, 2026	2026 (Q2)	0.19 / -0.04	1.686	-102.65% (-1.73)
May 06, 2026	2026 (Q1)	0.87 / 2.57	-4.102	162.61% (+6.67)
Feb 25, 2026	2025 (Q4)	-1.07 / -3.50	1.338	-362.00% (-4.84)
Nov 03, 2025	2025 (Q3)	-0.65 / -1.61	0.303	-629.41% (-1.91)
Aug 06, 2025	2025 (Q2)	0.74 / 1.69	0.062	2600.00% (+1.62)
May 06, 2025	2025 (Q1)	-2.86 / -4.10	0.33	-1343.24% (-4.43)
Feb 26, 2025	2024 (Q4)	1.68 / 1.34	0.419	219.15% (+0.92)
Nov 06, 2024	2024 (Q3)	-0.07 / 0.30	-0.41	173.91% (+0.71)
Aug 07, 2024	2024 (Q2)	-0.12 / 0.06	-0.241	125.93% (+0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed